Cann-Expo
21 - 22 October, 2020 | Helexpo Maroussi, Athens, Greece
www.cann-expo.com
Cann-Expo 2020. The Future of Cannabis.
“Success for cannabis companies will hinge on whether they can implement a successful supply chain strategy to address all of the initial issues. Those that get their supply chains right have the opportunity to become market leaders, while those that do not are likely to incur excessive costs, miss commitments and lose market share.”- PwC Canada
“When you look at the medical cannabis industry, the technologies that are being used are not very high-end. The biotech and agritech areas are lacking new technologies.” - Lilac Mandeles, CEO, TechForCann
“We see being in Greece as a springboard to the rest of Europe because of its location. They have a stable political situation, an economy ripe for a new industry and it’s a natural for cultivation” – Jay McMillan, VP Strategic Business Development, Hexo Corp
“When you look at the medical cannabis industry, the technologies that are being used are not very high-end. The biotech and agritech areas are lacking new technologies.” - Lilac Mandeles, CEO, TechForCann
“We see being in Greece as a springboard to the rest of Europe because of its location. They have a stable political situation, an economy ripe for a new industry and it’s a natural for cultivation” – Jay McMillan, VP Strategic Business Development, Hexo Corp
Cann-Expo is the first ever international B2B medical cannabis conference & exhibition to take place in Greece, providing key access to the Middle Eastern, Asian, African and European markets. The event will act as an international platform for industry executives and leaders to discuss, develop and establish a standardised industry framework for the production of medical cannabis across the globe.
Discussing key challenges in the industry such as:
Navigating the tangled regulatory landscape
Manoeuvering goods according to disjointed import and export policy
Ensuring the safety and efficacy of cannabinoid products and medicines
Maintaining the quality and consistency of product
Breaking the stigma and educating the professionals, the patients and the public
Building a greater body of scientific and evidence backed data
Improving distribution networks to improve patient access
And addressing them from the perspectives of the cultivation, manufacture and distribution of medical cannabis.
We will encourage the growth of a recognised, responsible and regulated medical cannabis industry by
Providing a forum for deep discussion
Exploring case studies from leading companies
Sharing best practice in manufacturing
Bringing together the most influential players from all areas of the medical cannabis supply chain, Cann-Expo provides a space for buyers and sellers to learn, debate, benchmark, network, and do business.
Featured Speakers
David Badcock
CEO
Drug Science
Dr. Isaac Balbin
Founder & CEO
Parsl
Mark Braunstein
Medical Director
Medicinal Mindfulness
Rikke Jakobsen
Head of Secretariat
Cannabis Denmark
Jennifer Lee
Managing Partner, Growth Platforms
Deloitte.
David Attwood
Director of Strategy & Business Development
CanPharma
Shlomo Booklin
Freelance
Freelance
Michael Verbora
Chief Medical Officer
Aleafia Health
Ryan Douglas
Cannabis Growth Consultant
Ryan Douglas Cultivation, LLC
Who will attend?
Licensed Producers / Growers
Health & Wellness Brands
Pharmaceuticals/ Phytopharma/ Biomedical/ Biotech
Nutraceuticals
Healthcare Providers
Pet food brands
Licensed Medical Cannabis Importers / wholesalers
Sports Nutrition brands
FMCG – Food & Beverages
Academia & Government
Cosmetic companies
Financiers/ VC/ Incubators/ Angel capital
Who will exhibit?
Cultivation Products and services
Extraction & Processing equipment suppliers
Investors/ Banks/ Hedge Funds/ VC’s
Lab Testing Services
Legal services
Manufacturing equipment
Packaging & Supplies
Processors
Real estate companies
Security solution providers
Software & Tech providers
Training & Educational providers
Event Partners and Sponsors
Media Partners
